InterventionsHuman trial120 participants24 weeksRandomised trialDouble-blindPlacebo-controlledDose-responseMulticentreRegistered NCT06973681
Effectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
Diabetes, Obesity & Metabolism
The paper
Linong Ji, Guoping Yang, Yangqing Huang, Jiandong Yuan
Show 7 more authors
Haifeng Ding, Daosheng Xie, Xiaohui Jiang, Xuemei Yuan, Zhao Cao, 邹婵 ZOU Chan, Haibin Zhang,Peking University People's Hospital · Central South University
Diabetes, Obesity & Metabolism · 17 Sep 2026